Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 3/20 | 0.36 |
| ▸ | CDK9 | P50750 | 1/20 | 0.36 |
| ▸ | BCDIN3D | Q7Z5W3 | 2/20 | 0.36 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.34 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | TRIM58 | Q8NG06 | 1/20 | 0.31 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.31 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.31 |
| ▸ | GPR39 | O43194 | 1/20 | 0.30 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | KHK | P50053 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16094309 | 0.85 | HRH4 (0.40) | BCDIN3DHRH4KDM4EATMTRIM58 | |
| SCHEMBL30560032 | 0.85 | CDK2 (0.38) | CDK2CDK9BCDIN3DCCNA2CCNA1 | |
| SCHEMBL20164687 | 0.85 | CDK2 (0.38) | CDK2CDK9BCDIN3DCCNA2CCNA1 | |
| SCHEMBL20164463 | 0.85 | CDK2 (0.37) | CDK2CDK9BCDIN3DCCNA2CCNA1 | |
| SCHEMBL20164481 | 0.85 | CDK2 (0.37) | CDK2CDK9BCDIN3DCCNA2CCNA1 | |
| SCHEMBL20164464 | 0.85 | CDK2 (0.37) | CDK2CDK9BCDIN3DCCNA2CCNA1 | |
| Hydrochloric Acid SCHEMBL20164747 | 0.84 | CDK2 (0.38) | CDK2CDK9BCDIN3DCCNA2CCNA1 | |
| Hydrochloric Acid SCHEMBL16093980 | 0.84 | HRH4 (0.40) | CDK2CDK9BCDIN3DHRH4KDM4E | |
| Hydrochloric Acid SCHEMBL20164740 | 0.84 | CDK2 (0.36) | CDK2CDK9BCDIN3DCCNA2CCNA1 | |
| Hydrochloric Acid SCHEMBL20164433 | 0.84 | CDK2 (0.36) | CDK2CDK9BCDIN3DCCNA2CCNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10294228-B2 | Breathing control modulating compounds, and methods of making and using same | NEURAD LTD. (IL) | 2019-05-21 | — | — | US | disclosed |
| US-20180141953-A1 | Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same | NEURAD LTD. (IL) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180141953-A1 | Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same | MTNR1B, CHRM3, PER2 | CDK2 4026/4885CDK9 4092/4885BCDIN3D 1317/4885 |
| US-10294228-B2 | Breathing control modulating compounds, and methods of making and using same | MTNR1B, PDE3A, CHRM3 | CDK2 4190/4885CDK9 4292/4885BCDIN3D 1281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.